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The Advisory Committee on Immunization 
Practices (ACIP) met June 25-26, 2008.  At 
this meeting the ACIP recommended two new 
vaccines (Pentacel and KINRIX), voted to 
include them in the Vaccines for Children 
(VFC) Program, and provided 
recommendations on harmonizing the 
schedule for the two rotavirus vaccines 
(Rotarix and RotaTeq).   
Pentacel DTaP-IPV/Hib (Sanofi Pasteur) 
is a combination vaccine that contains 
5 antigens to protect against 
diphtheria, tetanus, pertussis, 
poliomyelitis, and invasive disease due 
to Haemophilus influenzae type b 
(Hib).  The vaccine was licensed by the 
U.S. Food and Drug Administration 
(FDA) on June 20, 2008, for use in 
children 2 months through 4 years of 
age.  This vaccine can be used for the 
primary series and the first booster 
dose (total of four doses).   
As with all combination vaccines the 
schedule, minimum intervals, and 
minimum ages are determined by the 
individual antigens.  The 
recommended schedule for Pentacel is 2, 4, 6, 
and 15 through 18 months of age.  
The vaccine is supplied in a 5 dose package.  A 
single dose vial of liquid DTaP-IPV vaccine is 
used to reconstitute a single-dose vial of 
lyophilized ActHIB vaccine, and should be 
used immediately after reconstitution.  The 
administration route is intramuscular (IM) 
injection.  Store the vaccine at refrigerator 
temperature, 35-46o F.  
 IMPORTANT NOTE:  The availability of 
Pentacel will improve the Hib supply 
situation in the United States.  However, the 
availability of Pentacel is not 
sufficient to reinstate the 
booster dose in the Hib 
vaccine series.   
Although Pentacel is licensed 
by the FDA for the fourth 
dose in the DTaP, IPV and 
Hib series, providers should 
NOT use Pentacel for the 
fourth dose until there is 
further improvement in the 
Hib supply (anticipated 
during the last quarter of 
2008).  Until the Hib supply 
improves, Pentacel should be 
used ONLY for the first three 
doses of the DTaP, IPV, and Hib vaccination 
series. 
Continued on page 2 
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ACIP Recommends New Childhood Vaccines 
Mark Your Calendars! 
The Iowa Statewide Immunization Conference 
will be held in Des Moines on June 11, 2009, 
at the Hy-Vee Hall in Downtown Des Moines.   
Our 2007 conference had more than 600 participants, making it one of the largest state immuni-
zation conferences in the nation!  As a result, the IDPH Immunization Program has secured a 
new conference site to accommodate our growing attendance—Hy-Vee Hall in Downtown Des 
Moines (attached to Veterans Auditorium).   
We are currently planning the conference and are pleased to bring national speakers to Iowa 
again, such as Dr. Paul Offit of the Children’s Hospital of Philadelphia and Dr. Bill Atkinson of 
the CDCs National Immunization Program. Look for more information to come after the first of 
the year.  See you there! 
October 2008 Volume 1, issue 9 
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KINRIX  DTaP/IPV (GSK) is a 
combination vaccine that contains 4 
antigens to protect against diphtheria, 
tetanus, pertussis and poliomyelitis.   
The vaccine was licensed by the FDA on 
June 24, 2008, and is indicated for the 
fifth dose in the DTaP series and the 
fourth dose in the IPV series in children 4 
through 6 years of age whose previous 
DTaP vaccine doses have been with 
Infanrix and/or Pediarix.   
The vaccine is supplied in a single dose 
vial or prefilled syringe.  The 
administration route is 
intramuscular (IM) injection.  
Store the vaccine at refrigerator 
temperature, 35-46o F,. 
Rotarix (GSK) On April 3, 2008, 
the FDA approved Rotarix, a 2-
dose vaccine that provides 
protection against rotavirus.   
In February 2006, Merck’s 
RotaTeq, was recommended for 
routine use in infants by the ACIP 
for protection against rotavirus.  
The administration route is oral.  
Store the vaccine at refrigerator 
ACIP Recommends New Childhood Vaccines, Continued 
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It’s Their Turn! Initiative 
Supporting Adolescent Immunization in your Health Department  
CDC has recently 
launched the It’s Their 
Turn! Initiative.  
This initiative provides 
clinics working with 
teens with a 
comprehensive set of 
tools and materials to 
assist in implementing 
educational and 
awareness campaigns to 
promote adolescent 
immunization.  
It’s Their Turn! offers 
an array of materials 
from letters to multiple 
audiences, press 
releases, and posters and 
flyers, to cutting edge e-
materials such as 
podcasts and e-cards.  
The initiative 
also provides 
mechanisms 
to obtain 
public and 
media 
attention for 
adolescent 
immunization 
efforts.  
Health 
departments 
can utilize 
these 
materials to 
reach key 
target 
audiences, 
including 
parents, health 
care providers, 
and 
adolescents.  
All materials can be easily adapted to 
each department’s needs. This initiative 
provides health departments with the 
flexibility to tailor their messages and 
focus on specific aspects of adolescent 
immunization including responding to 
communication/education needs around 
outbreaks.  
A few states are already using It's Their 
Turn! with great success.  To view the 
It’s Their Turn! Initiative and learn 
how to best optimize these tools, please 
visit the CDC website at 
http://www.cdc.gov/vaccines/spec-
grps/preteens-adol/prof-matls/state-
materials.htm. 
Contact Kelly Rooney-Kozak at 1-800-
831-6293, ext 9 with questions regarding 
Iowa’s Adolescent Immunization 
Program.    
temperature, 35-46o F,  and protect from 
light.        
The two rotavirus vaccines differ in 
composition and schedule.  The ACIP 
does not express a preference for either 
vaccine when providers vaccinate their 
patients.  The harmonized schedule 
approved by the ACIP is highlighted 
below.  
The ACIP voted to include Pentacel, 
KINRIX, and Rotavrix  vaccines in the 
VFC Program.  Beginning October 1, 
2008, these products are available 
through the Iowa VFC Program. 
The VFC Program reminds providers to 
use their existing supply of single and 
combination vaccines prior to ordering 
new combination vaccines.  
For questions regarding vaccines, contact 
Terri Thornton or Bridget Konz at 1-800-
831-6293, ext 2 and 7 respectively.  For 
vaccine ordering questions, contact 
Janean Iddings at 1-800-831-6293, ext 5. 
 Harmonized schedule  RotaTeq (RV5-Merck)  Rotarix (RV1-GSK)  
Number of doses in series                   3                2 
Recommended ages for doses 2, 4, and 6 months 2 and 4 months 
Minimum age for first dose 6 weeks 6 weeks 
Maximum age for first dose 14 weeks 6 days 14 weeks 6 days 
Minimum interval between 
doses 
4 weeks 4 weeks 
Maximum age for last dose 8 months 0 days 8 months 0 days 
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Joint Commission Resources Challenges Hospitals to Increase             
Influenza Immunization of Healthcare  Personnel  
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Joint Commission Resources (JCR), a 
non-profit affiliate of the Joint 
Commission, has issued a challenge to 
hospitals to increase influenza 
vaccination rates among healthcare 
personnel. Portions of a document posted 
on the JCR website are reprinted here:  
JCR has launched a Flu Vaccination 
Challenge to underscore the 
responsibility that hospitals have to help 
keep their employees and patients healthy 
this flu season.  
The Flu Vaccination Challenge is 
designed to increase flu vaccination rates 
among healthcare workers. According to 
the Centers for Disease Control and 
Prevention (CDC), in the 2005-2006 flu 
season, only 42 percent of surveyed 
healthcare workers received a flu 
vaccination.  
In past years, flu infections have been 
documented in healthcare settings and 
healthcare workers have been 
implicated as the potential source of 
these infections. JCR challenges 
hospitals to achieve higher vaccination 
rates among their staff. 
The Flu Vaccination Challenge begins in 
September 2008 and will continue 
through the flu season until May 2009. 
Hospitals that achieve a vaccination rate 
of 43 percent or more will be recognized 
for their dedication 
to helping keep their 
employees healthy 
and helping to 
protect their 
patients. Vaccination 
of healthcare workers 
may help to decrease 
the chances that they 
will get the flu and 
pass it on to their 
patients.  
"The Flu Vaccination 
Challenge highlights 
for healthcare 
workers the value 
that flu vaccinations 
can have on patient 
safety. Doctors, 
nurses, technical, 
and administrative 
staff may care for patients with 
compromised immune systems 
including the elderly and people living 
with a chronic disease. As a professional 
devoted to 'do no harm,' flu vaccination 
gives me an opportunity to help protect 
my patients by decreasing the chances 
that I will get the flu and pass it along to 
my patients"  said Barbara M. Soule, RN, 
MPA, CIC, practice leader, Infection 
Prevention and Control Services, JCR. 
The flu is a serious disease that can be 
potentially fatal. The ACIP recommends 
an annual flu vaccination for a number of 
groups, including adults at high risk of 
complications from the flu and those who 
are in contact with them, including 
healthcare workers.  
Efforts to increase vaccination coverage 
among healthcare workers are supported 
by various national accrediting and 
professional organizations including The 
Joint Commission. Since January 1, 
2007, The Joint Commission has 
required accredited hospitals, critical 
access hospitals, and long-term care 
organizations to offer the flu vaccination 
annually, on site, to staff and licensed 
independent practitioners. 
"Every year in the United States up to 20 
percent of the population is affected by 
influenza and more than 200,000 people 
are hospitalized from influenza 
complications. It is crucial that 
healthcare workers receive their 
influenza vaccination each year to help 
curb the spread of this preventable 
disease," said Dr. William Schaffner, 
chairman, Department of Preventive 
Medicine, and professor of infectious 
diseases at Vanderbilt University School 
of Medicine. . . .  
To access the complete document, and to 
register your hospital, go to: 
http://www.fluvaccinationchallenge.com  
“It is crucial that healthcare workers receive their influenza 
vaccination each year to help curb the spread of this pre-
ventable disease”  Dr. William Schaffner 
 VFC Vaccine Ordering Reminder: 
 If your clinic orders vaccine by faxing your order to the Immunization Program (i.e. you are not 
an IRIS user) remember that doses on hand MUST be completed for all vaccines in your         
inventory, not just those you are ordering at that time.  Immunization Program staff review the 
doses on hand prior to submitting your order to McKesson.  Without a complete understanding 
of your vaccine supply we will not be able to complete your order.  If you have questions, please 
contact Janean Iddings at 1-800-831-6293, ext 5. 
Do you want to have the Immunization Update Newsletter sent to you directly? Do you know someone who would?  
Send your name and mailing address to Bkonz@idph.state.ia.us and we will sign you up—it’s as easy as that!  The Immunization 
Update is also available on our Web page at: www.idph.state.ia.us/adper/immunization.asp It’s a great way to send the Newsletter 
on to others in your facility or community. 
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Question:  I  
heard the local 
public health 
agencies  will be  
able to bill Well-
mark for vacci-
nations provided to Wellmark policy 
holders.  Is this true? 
Answer:  Yes.  Soon, public health agen-
cies  will be eligible to enroll with Well-
mark Blue Cross and Blue Shield. Well-
mark is planning to expand its network of 
eligible providers to increase access op-
tions for members who have immuniza-
tion benefits. Watch your mail for a letter 
from Wellmark that will include more 
information, or periodically check Well-
mark’s Web site at www.wellmark.com   
 
Question: Is Prevnar going to be re-
quired for children entering licensed child 
care in Iowa?  If so, when?  
Answer:  Yes, Pneumococcal Conjugate 
(Prevnar) will be required for children 
entering licensed child care.  The Iowa 
Legislature passed a bill requiring this 
vaccine in 2007 and the Immunization 
Program is currently working through the 
Administrative Rules process to incorpo-
rate Prevnar into the schedule.  The Im-
On August 1, 2008, a MMWR titled 
“Newborn Hepatitis B Vaccination    
Coverage Among Children Born January 
2003-June 2005” was published by 
CDC.  In that article data was published 
for each state and some cities regarding 
their rate of initiation of the Hepatitis B 
birth dose.   
 
Iowa had a rate of 23 percent of infants 
vaccinated with the Hepatitis B birth 
dose by 3 days of age.  This is the 4th 
lowest state rate in the nation.  Ne-
braska, Minnesota, and Vermont all had 
rates lower than Iowa.  The highest state 
was Massachusetts with 85 percent of 
infants receiving the birth dose by 3 days 
of age.    
 
This low rate of Hepatitis B birth dose 
initiation indicates that Iowa providers 
and OB hospitals must focus their efforts 
in providing education and stressing the 
importance of the birth dose.   
Getting the birth dose is NOT “just an-
other shot” as some health care workers 
munization Program anticipates rules to 
be effective in early 2009. 
 
Question:  Is the Health Protection 
Clearinghouse in Cedar Rapids I order 
immunization print materials going to be 
open soon?  I am concerned about having 
enough VISs for flu season. 
Answer:  The clearinghouse was damaged 
severely enough in the flooding that they 
are moving to a new building.  At this time 
we do not have a date they will begin ship-
ping products for us.  Please plan to copy 
enough VISs for your clinic needs.  
 
Question:  What is a good resource for flu 
information to give parents, besides the 
VIS?  
Answer:  The Vaccine Education Center at 
the Children’s Hospital of Philadelphia re-
cently updated its two-page education 
sheet, “Influenza:  What you should know.”  
Intended for patients, parents, and provid-
ers, the sheet answers the most frequently 
asked questions about influenza disease 
and vaccines.  
www.chop.edu/vaccine/images/vec_influ_
tear.pdf 
Question Corner 
Call to Action: You Can Help Increase Iowa’s Birth Dose Rate! 
IRIS 
IRIS data integ-
rity and quality is 
of utmost impor-
tance to the Im-
munization Pro-
gram. Currently, IRIS contains over 1.6 
million patient records with more than 
13 million vaccinations. With this vol-
ume of data, it is important to main-
tain high standards so that records are 
accurate, and correct data is available 
to healthcare providers in Iowa.  
When entering patient information in 
IRIS, it is important to enter as much 
information as possible and correctly.  
If patient information is unavailable, 
such as social security number or 
mother’s maiden name, these fields 
should be left blank.  Entering incor-
rect or false data results in records that 
are not useful in identifying a patient 
and dilutes the integrity of the records.  
If you have questions regarding IRIS 
and patient information, please call 
the IRIS Help Desk at 800-374-3958.  
Thank you for your continued support 
of IRIS and assistance in maintaining 
the highest quality of data.   
claim.  The importance of initiating the birth 
dose is apparent when it is 
realized that infants infected 
with HBV typically are asymp-
tomatic and have a 90% likeli-
hood of remaining chronically 
infected.  Up to 25% of chroni-
cally infected children die pre-
maturely of cirrhosis or liver 
cancer.  
Two primary modes of HBV 
transmission occur during in-
fancy and early childhood:  
1) from an infected mother 
to her infant during deliv-
ery, and  
2) from infected household 
contacts to infant or 
child.  
Both modes of transmission can be pre-
vented by immunization of newborn infants. 
Hepatitis B vaccination of all newborns also 
provides early pre-exposure protection to 
infants born to uninfected women   
during a period when 
the risk for developing 
chronic HBV infection 
is greatest.” (MMWR, 
Volume 57, NO. 30, 
August 1, 2008)  The 
Iowa Immunization 
Program is committed 
to increasing the  
Hepatitis B birth dose 
rate.   
For more information 
on Hepatitis B birth 
dose or how your hos-
pital can participate in 
providing the birth 
dose, contact Bridget 
Konz, RN, Perinatal 
Hepatitis B                
Coordinator at 1-800-831-6293, ext 7 
or bkonz@idph.state.ia.us.   
To view the entire MMWR go to: 
http://www.cdc.gov/mmwr/preview/m
mwrhtml/mm5730a3.htm?s_cid=mm5
730a3_e 
Iowa Ranked 46th in the U.S. for 
Hepatitis B Birth Dose Rates.  
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VFC Influenza Update 
During the 2008-2009 influenza season 
there is an expansion of children recom-
mended for influenza vaccination.  Chil-
dren five through 18 years of age should 
be vaccinated against influenza begin-
ning in 2008.  Children six months of 
age to five years of age are already rec-
ommended for vaccination. 
 Orders: For the 2008-2009 influenza 
season the Iowa Vaccines for Children 
(VFC) Program will be distributing Flu-
zone and Flumist brands of influenza 
vaccine (shaded on the table below).  
The table below lists all approved influ-
enza vaccines for different age groups in 
the United States for this influenza sea-
son.  Orders that were pre-booked ear-
lier this year will be processed once 
product is available.   
Distribution: Distribution of influ-
enza vaccine will begin once sufficient 
doses of product arrive at McKesson. 
Influenza vaccine will be sent to 
McKesson in phased allotments from 
the manufacturer. The Program antici-
pates the arrival of influenza vaccine 
shipments in September and continu-
ing throughout October.  Influenza 
vaccine orders will ship separately 
from regular vaccine orders.  
Eligible Groups: Influenza vac-
cine that is received from the 
Iowa Department of Public 
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Health may be administered to any 
VFC eligible child 6 months through 
18 years of age, regardless of risk 
factor.  Most children need one dose of 
influenza vaccine, with the following ex-
ceptions:    
• Children under age 9 years receiving 
influenza vaccine for the first time 
need two doses separated by 4 weeks 
(1 month). 
• Children under age 9 years who re-
ceived influenza vaccine for the first 
time in the 2007-2008 season and 
did not receive both doses that season 
need 2 doses this season separated by 
4 weeks (1 month).  
Vaccine University 2008   
Thank you to all the participants of Vaccine University 2008!  Through our IRIS Training, Vaccine 101, 
and Storage and Handling classes we provided education to over 800 participants across Iowa!  We are 
excited about the responses we received and will use the evaluations to plan for Vaccine University 
2009.  No dates have been set for 2009, however we will advertise once classes, dates, and locations 
have been determined.  We look forward to seeing you there! 
Type Trade 
Name 
Manufac-
turer Presentation 
Mercury content 
(mcg Hg/0.5 mL 
dose) 
Age Group No. of 
Doses Route 
TIV* Fluzone sanofi pasteur 0.25 mL pre-filled syringe 
0.5 mL pre-filled syringe 
0.5 mL vial 
5.0 mL multi-dose vial 
0 
0 
0 
25 
6–35 mos 
>36 mos 
>36 mos 
>6 mos 
1 or 2† 
1 or 2† 
1 or 2† 
1 or 2† 
Intramuscular§ 
Intramuscular§ 
Intramuscular§ 
Intramuscular§ 
TIV* Fluvirin Novartis  
Vaccine 
5.0 mL multi-dose vial 
0.5 mL pre-filled syringe 
24.5 
<1.0 
>4 years 
>4 years 
1 or 2† 
1 or 2† 
Intramuscular§ 
Intramuscular§ 
TIV* Fluarix GlaxoSmith-
Kline 
0.5 mL pre-filled syringe <1.0 >18 years 1 Intramuscular§ 
TIV* FluLuval GlaxoSmith-
Kline 
5.0 mL multi-dose vial 25 >18 years 1 Intramuscular§ 
TIV* Afluria CSL  
Biotherapies 
0.5 mL pre-filled syringe 
5.0 mL multi-dose vial 
0 
25 
>18 years 
>18 years 
1 
1 
Intramuscular§ 
Intramuscular 
LAIV
¶ 
FluMist** MedImmune 0.2 mL sprayer 0 2–49 years 1 or 2†† Intranasal 
Approved influenza vaccines for different age groups — United States, 2008–09 season  
*Trivalent inactivated vaccine (TIV). A 0.5-mL dose contains 15 mcg each of A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2)-like, and 
B/Florida/4/2006-like antigens.  
† Two doses administered at least 1 month apart are recommended for children aged 6 months through 8 years who are receiving TIV for the first time and those who 
only received one dose in 2007-2008 should receive 2 doses this year. 
§ For adults and older children, the recommended site of vaccination is the deltoid muscle. The preferred site for infants and young children is the anterolateral aspect 
of the thigh.  
¶ Live attenuated influenza vaccine (LAIV). A 0.2-mL dose contains 106.5–7.5 fluorescent focal units of live attenuated influenza virus reassortants of each of the three 
strains for the 2008–09 influenza season: A/Brisbane/59/2007(H1N1), A/Brisbane/10/2007(H3N2), and B/Florida/4/2006.  
** FluMist is shipped refrigerated and stored in the refrigerator at 2°C to 8°C after arrival in the vaccination clinic. The dose is 0.2 mL divided equally between each 
nostril. Health-care providers should consult the medical record, when available, to identify children aged 2–4 years with asthma or recurrent wheezing that might 
indicate asthma. In addition, to identify children who might be at greater risk for asthma and possibly at increased risk for wheezing after receiving LAIV, parents or 
caregivers of children aged 2–4 years should be asked: “In the past 12 months, has a health-care provider ever told you that your child had wheezing or asthma?” Chil-
dren whose parents or caregivers answer “yes” to this question and children who have asthma or who had a wheezing episode noted in the medical record during the 
preceding 12 months, should not receive FluMist.  
†† Two doses administered at least 4 weeks apart are recommended for children aged 2–8 years who are receiving LAIV for the first time, and those who only received 1 
dose in their first year of vaccination should receive 2 doses in the following year. 
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 10. Hand washing is more effective 
than getting the vaccine. The good 
news is people have heard the message 
about hygiene and flu prevention. The 
bad news is people mistakenly believe 
that hand washing alone will prevent in-
fluenza. What providers can do:  Promote 
immunization, hand washing, and antivi-
ral medication as a three-part flu protec-
tion strategy.   
 9. Only the very old and the very 
young need the flu shot. Young chil-
dren and the elderly are at high risk from 
flu complications, but people of all ages 
can become sick-and they can pass the 
virus on to others. What providers can do: 
Encourage flu vacci-
nation as “a way to 
protect yourself and 
others.” Many people 
are more compelled to 
get a flu shot if they 
know it will protect a 
loved one’s health.   
 8. Flu shots are scarce and hard to 
find.  Manufacturers have more than 
doubled the amount of flu vaccine pro-
duced since 2004, and this year’s supply 
is projected to be ample.  What providers 
can do: Spread the message that anyone 
who wants a flu vaccine should contact 
their provider. 
 7. Getting a flu shot is a hassle. 
Many flu clinics are hosted in convenient 
places, such as work sites, pharmacies, 
supermarkets, and schools. What provid-
ers can do: Publicize locations of flu clin-
ics in your area and the ease with which 
people are immunized.     
 6. Flu shots don’t work.  Each year 
scientists develop vaccines based on pro-
jections for the upcoming flu season-and 
they’ve made successful matches 16 of 
the last 21 years. Even if a person be-
comes ill from a strain not covered by the 
vaccine, a flu shot can minimize symp-
toms and speed up recovery. What pro-
viders can do: Acknowledge that there 
may be unexpected changes in the flu 
strain, but stress that the vaccine has a 
long success rate for preventing the flu 
and can help make the disease less severe 
if contracted. 
 5. Flu shots will make you sick.  Flu 
vaccines are very safe, but like any medi-
cine side effects may occur.  Most often 
they are mild and include soreness from 
the injection, aches, and low 
grade fever. The flu vaccine, 
however, cannot give anyone 
the flu. What providers can 
do: Educate people about side 
effects and explain that they 
may occur as the body devel-
ops immunity.  Point out that 
these symptoms are much less severe 
than getting the flu.    
 4. There are unsafe ingredients in 
flu shots.  Recent media speculation 
about vaccine safety may raise concerns 
about the flu shot. The vaccine, however, 
has a strong safety record. Healthcare 
providers are key in addressing questions 
and helping patients make an informed 
choice.  What providers can do: Talk with 
patients about the flu vaccine and pro-
vide resources, such as brochures, post-
ers, and PSAs, to encourage dialogue. 
Visit the CDC influenza Web site for free 
resources 
(www.cdc.gov/flu/professionals/flugaller
y/index.htm). 
 3. Flu shots are expensive.  Flu shots 
average about 
$25-$35 a dose. Medicare Part B and 
Vaccines for Children provide flu shots at 
no cost to those who qualify.  Many em-
ployers provide free vaccines to their em-
ployees, and university health centers 
often provide discounted immunizations 
for students. Even if paying out of pocket, 
the cost of a flu shot is far less than the 
costs associated with missing work and 
needing health care. What providers can 
do: Connect low and middle income peo-
ple with resources to obtain free or re-
duced cost immunizations.  
 2. If I don’t get my flu shot early, 
than it’s not worth it.  There is no time 
limit on when to get flu vaccine.  Immuni-
zation can begin as soon as the vaccine is 
available and can extend through Febru-
ary or later- when the flu season typically 
peaks.  What providers can do: Promote 
National Influenza Vaccination Week 
from December 8-14th to encourage 
those not vaccinated to get their flu shot.  
Visit www.cdc.gov/flu/nivw/NIVW2008-
index.htm for more information.  
 1. I don’t need to get immu-
nized, because the flu is no big 
deal. Many people mistakenly attribute 
cold symptoms, mild illness, and even 
digestive upset to the flu, not realizing 
that influenza is a serious, sometimes life 
threatening respiratory infection.  What 
providers can do: Educate your commu-
nity about the seriousness of the flu, so 
people understand the need for immuni-
zation. Personal narratives are effective 
ways to deliver this message.  The CDC 
(www.cdc.gov/flu) and Families Fighting 
Flu Web sites 
(www.familiesfightingflu.org/) have vid-
eos and fact sheets to help with your out-
reach efforts.   
Have you Heard These?   
10 Myths About Getting the Flu Vaccine  
National Influenza Week 
is December 8-14, 2008.  
Visit the following CDC Web 
site for more in formation:  
http://www.cdc.gov/flu/NIV
W/index.htm 
On September 5, 2008, an MMWR entitled “National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 
Months” was published.  This MMWR evaluates the immunization rates reported by states and compares them nationally.   
The 2007 survey shows sustained record levels of immunization coverage in children 19 to 35 months of age.  In the U.S. 77.4 per-
cent of children receive the full series of vaccines and Iowa had a rate of nearly 76 percent of children receiving a full series. Each 
year the national vaccination program prevents 14 million infections, 33,000 premature lives lost and saves approximately $44 
billion in direct and indirect costs.   
To review the full MMWR please go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5735a1.htm?s_cid=mm5735a1_e 
Vaccination Coverage Among Children 19 to 35 Months of Age 
